SCHEMBL11323799

SCHEMBL11323799

NC(=O)c1cc2cnccn2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIRT3 Q9NTG7 2/20 0.42
F7 P08709 1/20 0.42
F3 P13726 1/20 0.42
SARM1 Q6SZW1 1/20 0.42
SIRT2 Q8IXJ6 1/20 0.42
SIRT6 Q8N6T7 1/20 0.42
SIRT1 Q96EB6 1/20 0.42
SIRT5 Q9NXA8 1/20 0.42
SIRT4 Q9Y6E7 1/20 0.42
DYRK1A Q13627 2/20 0.40
CLK1 P49759 1/20 0.40
ADORA3 P0DMS8 1/20 0.39
TSHR P16473 1/20 0.39
MC4R P32245 1/20 0.39
ADRA1A P35348 1/20 0.39
MC3R P41968 1/20 0.39
MKNK1 Q9BUB5 8/20 0.37
MKNK2 Q9HBH9 8/20 0.37
TDP1 Q9NUW8 1/20 0.36
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27893222 0.84 HCAR2 (0.40) MKNK1MKNK2TDP1LMNA
SCHEMBL31751769 0.76 TBXAS1 (0.40) DYRK1ACLK1LMNATBXAS1AURKA
SCHEMBL31061962 0.75 SIRT2 (0.50) SIRT3F7F3SARM1SIRT2
SCHEMBL27154339 0.75 GRM5 (0.47) MAP4K4TBXAS1
SCHEMBL24159189 0.72 CDC7 (0.38) SIRT3F7F3SARM1SIRT2
SCHEMBL29986327 0.72 TBXAS1 (0.48) SIRT3F7F3SARM1SIRT2
SCHEMBL28000254 0.72 CLK1 (0.33) DYRK1ACLK1MKNK1MKNK2
SCHEMBL1421391 0.71 CHRNA7 (0.48) DYRK1ACLK1TSHRTDP1
Hydrochloric Acid SCHEMBL30204477 0.71 TBXAS1 (0.47) SIRT3F7F3SARM1SIRT2
Hydrochloric Acid SCHEMBL1421587 0.70 CHRNA7 (0.47) DYRK1ACLK1TSHRTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102844318-B Be used for the treatment of the compound of respiratory syncytial virus infection BIOTA SCIENTIFIC MANAGEMENT PTY LTD. (AU) 2016-04-13 CN claimed
EP-2665727-A1 BICYCLIC CARBOXAMIDE INHIBITORS OF KINASES Abbvie Inc. (US) 2013-11-27 EP claimed
CN-102844318-A Compounds for treating respiratory syncytial virus infections BIOTA SCIENT MAN 2012-12-26 CN claimed
WO-2012097684-A1 BICYCLIC CARBOXAMIDE INHIBITORS OF KINASES ABBOTT LABORATORIES (US) 2012-07-26 WO claimed
WO-2024044098-A2 PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS ALEXION PHARMACEUTICALS, INC. (US) 2024-02-29 WO disclosed
CN-102844318-B Be used for the treatment of the compound of respiratory syncytial virus infection BIOTA SCIENTIFIC MANAGEMENT PTY LTD. (AU) 2016-04-13 CN disclosed
CN-102844318-A Compounds for treating respiratory syncytial virus infections BIOTA SCIENT MAN 2012-12-26 CN disclosed